Reviews
Summary
Positives
- Patient reviews on WebMD show armodafinil has helped some CFS patients prescribed it off-label, with one noting they were still tired but “not utterly fatigued and exhausted as I was before” WebMD.
- Across narcolepsy reviews on Drugs.com, armodafinil averages 6.4/10 with 50% of patients reporting positive experience, including dramatic improvements in daytime alertness Drugs.com.
Negatives
- 24% of narcolepsy patients on Drugs.com report a negative experience, with side effects including headaches, dry mouth, cramping, nausea, loss of appetite, and dizziness, particularly at the start Drugs.com.
Hurdles & Side Effects
- One ME/CFS patient trying armodafinil reported a $550 monthly bill and said insurance only covered 90 percent after a back-and-forth prior authorization fight, while another gave up and switched to phentermine after a $700-plus monthly cash price plus an off-label denial Phoenix Rising.
- Cigna and most commercial plans require step-therapy documentation of a failed modafinil trial plus a sleep-study diagnosis (narcolepsy, OSA with CPAP, or shift-work disorder) before approving armodafinil, which leaves Long COVID patients without those labels paying $300-$625 cash for brand Nuvigil Cigna.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care